La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Titre (en) » - entrée « development »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
developing < development < developmental  Facettes :

List of bibliographic references indexed by development

Number of relevant bibliographic references: 75.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000086 (2017) Marina Picillo [Italie] ; Gustavo B. Vincos [Colombie] ; Francesco Sammartino [Canada] ; Andres M. Lozano [Canada] ; Alfonso Fasano [Canada]Exploring risk factors for stuttering development in Parkinson disease after deep brain stimulation.
000098 (2017) Lauren J. Van Scoy [États-Unis] ; Patrick J. Chiarolanzio [États-Unis] ; Cynthia Kim [États-Unis] ; Daren K. Heyland [Canada]Development and initial evaluation of an online decision support tool for families of patients with critical illness: A multicenter pilot study.
000157 (2016) James B. Koprich [Canada] ; Tom H. Johnston [Canada] ; Gabriela Reyes [Canada] ; Vanessa Omana [Canada] ; Jonathan M. Brotchie [Canada]Towards a Non-Human Primate Model of Alpha-Synucleinopathy for Development of Therapeutics for Parkinson’s Disease: Optimization of AAV1/2 Delivery Parameters to Drive Sustained Expression of Alpha Synuclein and Dopaminergic Degeneration in Macaque
000390 (2016) Anna R. Moverley ; Robin Waxman ; Maarten De Wit ; Andrew Parkinson ; Willemina Campbell ; Melanie Brooke ; Laure Gossec ; Philip S. Helliwell [Royaume-Uni]Development of a Flare Instrument for Use in Psoriatic Disease: A Report from the 2015 GRAPPA Annual Meeting.
000391 (2016) Philippe Finès [Canada] ; Rochelle Garner [Canada] ; Christina Bancej [Canada] ; Julie Bernier [Canada] ; Douglas G. ManuelDevelopment and implementation of microsimulation models of neurological conditions.
000425 (2016) Josie-Anne Bertrand [Canada] ; Anthony R. Mcintosh [Canada] ; Ronald B. Postuma [Canada] ; Natasha Kovacevic [Canada] ; Véronique Latreille [Canada] ; Michel Panisset [Canada] ; Sylvain Chouinard [Canada] ; Jean-François Gagnon [Canada]Brain Connectivity Alterations Are Associated with the Development of Dementia in Parkinson's Disease.
000531 (2015) Véronique Latreille [Canada] ; Julie Carrier [Canada] ; Marjolaine Lafortune [Canada] ; Ronald B. Postuma [Canada] ; Josie-Anne Bertrand [Canada] ; Michel Panisset [Canada] ; Sylvain Chouinard [Canada] ; Jean-François Gagnon [Canada]Sleep spindles in Parkinson's disease may predict the development of dementia.
000621 (2015) Nicole A. Capela [Canada] ; Edward D. Lemaire [Canada] ; Natalie Baddour [Canada]Novel algorithm for a smartphone-based 6-minute walk test application: algorithm, application development, and evaluation
000770 (2015) Cynthia L. Comella [États-Unis] ; Susan H. Fox [Canada] ; Kailash P. Bhatia [Royaume-Uni] ; Joel S. Perlmutter [États-Unis] ; Hyder A. Jinnah [États-Unis] ; Mateusz Zurowski [Canada] ; William M. Mcdonald [États-Unis] ; Laura Marsh [États-Unis] ; Ami R. Rosen [États-Unis] ; Tracy Waliczek [États-Unis] ; Laura J. Wright [États-Unis] ; Wendy R. Galpern [États-Unis] ; Glenn T. Stebbins [États-Unis]Development of the Comprehensive Cervical Dystonia Rating Scale: Methodology
000771 (2015) Line Beaudet [Canada] ; Francine Ducharme [Canada] ; Nathalie L'Écuyer [Canada] ; Sylvain Chouinard [Canada] ; Nicolas Jodoin [Canada] ; Michel Panisset [Canada]Development and evaluation of a dyadic intervention for elderly couples living with moderate-stage Parkinson disease.
000868 (2014) Barbara C. Tilley [États-Unis] ; Nancy R. Lapelle [États-Unis] ; Christopher G. Goetz [États-Unis] ; Glenn T. Stebbins [États-Unis]Using cognitive pretesting in scale development for Parkinson's disease: the Movement Disorder Society Unified Parkinson's Disease Rating Scale (MDS-UPDRS) example.
000880 (2014) Shirley H. Bush ; Salmaan Kanji ; José L. Pereira ; Daniel H. J. Davis ; David C. Currow ; David Meagher ; Kiran Rabheru ; David Wright ; Eduardo Bruera ; Michael Hartwick ; Pierre R. Gagnon ; Bruno Gagnon ; William Breitbart ; Laura Regnier ; Peter G. LawlorTreating an Established Episode of Delirium in Palliative Care: Expert Opinion and Review of the Current Evidence Base With Recommendations for Future Development
000887 (2014) Jamie Eberling [États-Unis] ; Lona Vincent [États-Unis] ; Jennifer G. Goldman ; Daniel Weintraub ; Jaime Kulisevsky ; Connie Marras ; Glenn Stebbins ; Karl KieburtzTherapeutic Development Paths for Cognitive Impairment in Parkinson's Disease: Report of a Regulatory Roundtable
000A12 (2014) Christian O'Reilly [Canada] ; Réjean Plamondon [Canada] ; Louise-Hélène Lebrun [Canada]Linking brain stroke risk factors to human movement features for the development of preventive tools
000A99 (2014) Noa Liscovitch [Israël] ; Leon French [Canada]Differential Co-Expression between α-Synuclein and IFN-γ Signaling Genes across Development and in Parkinson’s Disease
000B66 (2014) Christian Ineichen [Suisse] ; Walter Glannon [Canada] ; Yasin Temel [Pays-Bas] ; Christian R. Baumann [Suisse] ; Oguzkan Sürücü [Suisse]A critical reflection on the technological development of deep brain stimulation (DBS)
000B71 (2014) A. K. Lyseen [Danemark] ; C. N Hr [Danemark] ; E. M. S Rensen [Danemark] ; O. Gudes ; E. M. Geraghty [États-Unis] ; N. T. Shaw [Canada] ; C. Bivona-Tellez [États-Unis]A Review and Framework for Categorizing Current Research and Development in Health Related Geographical Information Systems (GIS) Studies
000C32 (2013) Bernard Le Foll [Canada] ; Abhiram Pushparaj [Canada] ; Yaroslaw Pryslawsky [Canada] ; Benoit Forget [France] ; Kiran Vemuri [États-Unis] ; Alexandros Makriyannis [États-Unis] ; Jose M. Trigo [Canada]Translational strategies for therapeutic development in nicotine addiction: Rethinking the conventional bench to bedside approach
000D42 (2013) Nicolas Morin [Canada] ; Laurent Grégoire ; Marc Morissette ; Sandrine Desrayaud ; Baltazar Gomez-Mancilla ; Fabrizio Gasparini ; Thérèse Di PaoloMPEP, an mGlu5 receptor antagonist, reduces the development of L-DOPA-induced motor complications in de novo parkinsonian monkeys: biochemical correlates.
000D75 (2013) Abdul Qayyum Rana [Canada] ; Wasim Mansoor ; Syed Hussaini ; Abdullah Al Mosabbir ; Maniza Rahman ; Labiba RahmanFactors associated with the development of impulse compulsive disorders in Parkinson patients.
000D85 (2013) Lucas M. Bronicki ; Bernard J. JasminEmerging complexity of the HuD/ELAVl4 gene; implications for neuronal development, function, and dysfunction

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "development" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "development" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    development
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022